Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)

Molecular Oncology
Lara BrambillaCarlo V Catapano

Abstract

STAT3 is a key element in many oncogenic pathways and, like other transcription factors, is an attractive target for development of novel anticancer drugs. However, interfering with STAT3 functions has been a difficult task and very few small molecule inhibitors have made their way to the clinic. OPB-31121, an anticancer compound currently in clinical trials, has been reported to affect STAT3 signaling, although its mechanism of action has not been unequivocally demonstrated. In this study, we used a combined computational and experimental approach to investigate the molecular target and the mode of interaction of OPB-31121 with STAT3. In parallel, similar studies were performed with known STAT3 inhibitors (STAT3i) to validate our approach. Computational docking and molecular dynamics simulation (MDS) showed that OPB-31121 interacted with high affinity with the SH2 domain of STAT3. Interestingly, there was no overlap of the OPB-31121 binding site with those of the other STAT3i. Computational predictions were confirmed by in vitro binding assays and competition experiments along with site-directed mutagenesis of critical residues in the STAT3 SH2 domain. Isothermal titration calorimetry experiments demonstrated the remarkably hi...Continue Reading

References

May 3, 2002·The Prostate·Rajiv DhirAllen C Gao
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·David E Levy, J E Darnell
Sep 3, 2004·The Journal of Clinical Investigation·Keith Syson ChanJohn DiGiovanni
Mar 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hui SongJiayuh Lin
Apr 20, 2005·Journal of Cellular Biochemistry·Zoran CuligAlfred Hobisch
May 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ling LiuNancy C Reich
Nov 23, 2006·Chemistry & Biology·Jochen SchustThorsten Berg
Jan 12, 2007·Molecular BioSystems·Cheh Peng Lim, Xinmin Cao
Apr 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Khandaker SiddiqueeJames Turkson
Jan 3, 2008·Cancer Cell·Sergei Grivennikov, Michael Karin
Aug 12, 2008·Seminars in Cell & Developmental Biology·Pravin B Sehgal
Jan 10, 2009·Science·Joanna WegrzynAndrew C Larner
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Jun 27, 2009·Science·Daniel J GoughDavid E Levy
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mustafa BenekliMeir Wetzler
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Jun 3, 2011·The Journal of Clinical Investigation·Lauren L C MarottaKornelia Polyak
Jun 28, 2011·The EMBO Journal·Ying-Jhen SuJia-Lin Lee
Feb 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pasquale Sansone, Jacqueline Bromberg
Mar 2, 2012·The Journal of Biological Chemistry·Olga A TimofeevaAnatoly Dritschilo
May 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Heehyoung LeeHua Yu
Jun 2, 2012·Journal of Medicinal Chemistry·Bikash DebnathNouri Neamati
Aug 2, 2013·Nature Reviews. Drug Discovery·Gabriella MiklossyJames Turkson
Jan 18, 2014·Seminars in Immunology·Jeremy A Meier, Andrew C Larner
Nov 10, 2011·ACS Medicinal Chemistry Letters·Erik LauriniSabrina Pricl

❮ Previous
Next ❯

Citations

Sep 24, 2015·Expert Opinion on Therapeutic Patents·Ping-Shan LaiPatrick T Gunning
Oct 20, 2015·Pharmacology & Therapeutics·Edna Zhi Pei ChaiGautam Sethi
Nov 19, 2015·Trends in Pharmacological Sciences·Chengguang ZhaoGuang Liang
Jun 21, 2016·Expert Opinion on Investigational Drugs·Catherine Cafferkey, Ian Chau
May 4, 2017·Expert Opinion on Therapeutic Patents·Prashant S Kharkar
Feb 7, 2018·Nature Reviews. Clinical Oncology·Daniel E JohnsonJennifer R Grandis
Aug 19, 2015·Cancer Growth and Metastasis·Sanjay PandeyBilikere S Dwarakanath
May 31, 2018·International Journal of Molecular Sciences·Jacopo SgrignaniAndrea Cavalli
Jul 13, 2018·Journal of Leukocyte Biology·Massimo GadinaJohn J O'Shea
Feb 10, 2018·Oncotarget·Konstantin MasliantsevLucie Karayan-Tapon
Jul 23, 2020·The Journal of Experimental Medicine·Catherine H PoholekMandy J McGeachy
Jun 7, 2017·Proceedings of the National Academy of Sciences of the United States of America·Davide GeniniCarlo V Catapano
Jun 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mélanie LambertMarie-Hélène David-Cordonnier
May 31, 2019·Frontiers in Oncology·Gianluca CivenniCarlo V Catapano
Nov 14, 2019·Cancers·Elvin D de AraujoPatrick T Gunning
Jan 23, 2020·Cancers·Marie Brachet-BotineauFabrice Gouilleux
Nov 2, 2019·Cancers·Yue-Ting K LauJennifer R Grandis
Nov 17, 2019·Cancers·Carol Lee, Siu Tim Cheung
Nov 19, 2020·Molecular Cancer Therapeutics·Jamie V ShiahDaniel E Johnson
Feb 7, 2021·Drug Discovery Today·Léopold ThabaultRaphaël Frédérick
Dec 30, 2020·Biomedicines·Thu-Huyen PhamDo-Young Yoon
Nov 8, 2020·International Journal of Molecular Sciences·Anna JaśkiewiczBeata Pająk
Dec 31, 2020·OncoTargets and Therapy·Yan LinRong Liang
Feb 19, 2021·Expert Opinion on Investigational Drugs·Matteo SantoniNicola Battelli
Apr 13, 2020·European Journal of Pharmacology·Tohid GharibiBehzad Baradaran
Nov 1, 2020·Journal of Dermatological Science·Huijuan MengXiangming Liu
Sep 10, 2019·ACS Omega·Francesc Sabanés ZariquieyAgnieszka K Bronowska

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.